Archive for the ‘Treatment’ Category

Benefits of Berberine Against Chronic Disease

https://www.foundmyfitness.com/topics/berberine?

Benefits of berberine against chronic disease

iu-69

By Rhonda Patrick

Background

Berberine is an alkaloid compound present in the roots, stems, rhizomes, and bark of a variety of plants, including Californian poppy, goldenseal, cork tree, Chinese goldthread, Oregon grape, and several plants in the Berberis genus. It is also widely available as a dietary supplement. Berberine has a long history of use in the ancient and traditional medicine systems of India, China, and Persia. Animal and limited human studies demonstrate that berberine may exert pharmacological effects against certain chronic health conditions such as cardiovascular disease, gastrointestinal disorders, neurodegenerative disease, depression, and metabolic dysfunction. Preliminary research in animals also suggests that berberine may exert anti-aging properties and might be beneficial in combating aging-related diseases. However, the bulk of research involving berberine has been conducted in animals, with a paucity of trials in humans. (See link for article)

___________________

**Comment**

Berberine has been a God-send for us.  It has been shown to:

  1. lower lipids
  2. have antioxidant properties
  3. have anti-inflammatory properties
  4. reduce blood glucose levels
  5. protect the liver (in cell-culture studies)
  6. help neurodegenerative disorders
  7. have anti-depressant effects (in mice)
  8. have anti aging effects (in cells, insects, and rodents)
  9. thwarts negative effects of some pharmaceutical drugs
  10. have action against Bartonella:  https://madisonarealymesupportgroup.com/2019/05/05/good-news-for-bartonella-patients-identification-of-fda-approved-drugs-with-higher-activity-than-current-front-line-drugs/

For more:  https://madisonarealymesupportgroup.com/2019/04/05/study-shows-berberine-induces-cell-death-in-leukemia/

Interestingly, Japanese Barberry, a source of Berberine, is a hot-spot for ticks.  https://madisonarealymesupportgroup.com/2015/09/30/barberry-friend-or-foe/

https://madisonarealymesupportgroup.com/2018/06/25/juvenile-tick-attachment-on-mice-significantly-greater-in-japanese-barberry-shrubs/

https://madisonarealymesupportgroup.com/2018/01/20/manage-barberry-lower-ticks/

COVID-19 Drug Remdesivir Could Cost Up To $3,120 Per Patient, Maker Says

https://www.drugs.com/news/covid-19-remdesivir-could-cost-up-3-120-per-patient-maker-says-

COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker Says

MONDAY, June 29, 2020 — The maker of remdesivir, the first drug that showed promise in treating coronavirus infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the drug company announced Monday.

Because of how the U.S. health care system is designed and the discounts that government health care programs like the VA and Medicaid will expect, the price for private insurance companies will be $520 per vial, Gilead Sciences explained in a letter. Most COVID-19 patients would need six vials of the drug over five days, the company said.

A lower price — $390 per vial — will be offered to other governments in developed countries around the world, Gilead added.

“As the world continues to reel from the human, social and economic impact of this pandemic, we believe that pricing remdesivir well below value is the right and responsible thing to do,” Gilead Chairman and CEO Daniel O’Day said in the company’s letter. (See link for article)

____________________

**Comment**

Our “authorities” have a financial conflict of interest in this expensive treatment:  https://principia-scientific.org/a-tale-of-2-drugs-deep-state-chose-money-power-over-lives/  Half of the COVID treatment panel has financial ties to Gilead Sciences:  https://covid19treatmentguidelines.nih.gov/panel-financial-disclosure/

Excerpt:

Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.

Going back to 1997, Donald Rumsfeld chaired the Board of Directors at Gilead and after 2001 he held share packages valued at $5-25 Million. Gilead originally developed Tamiflu. George P Shultz, US Secretary of State also was on the board. He sold stocks at a value of more than $7 million. CA governor’s Pete Wilson’s wife also sat on the board.

‘I don’t know of any biotech company that’s’ so politically well-connected [as Gilead],‘ Andrew McDonald, of the analyst firm Think Equity Partners, told Fortune.” (Source: “Virus Mania, How the Medical Industry Continually Invents Epidemics Making Billion Dollar Profits At Our Expense”)

This article also points out an ugly conflict of interest web between Gilead, the manufacturer of Remdesivir and UNITAID which Soros, Gates, and the Clinton Health Access Initiative, are large investors – with Drs. Fauci and Birx associated with the Clinton Health Access initiative.  https://www.thegatewaypundit.com/2020/06/stunning-faucis-remdesivir-costs-9-per-dose-will-sold-3000-per-dose-china-company-linked-soros-will-also-mass-produce-drug/  And of course, Dr. Fauci has worked with Gilead for a long, long time.

Government employees should not be allowed to have financial ties to manufacturing companies and then turn around and make public health policy.

Remdesivir isn’t cheap.  It costs between $520-$390 per vial and will be sold for $3,120 per 6 vial treatment:  That’s a lot of money for a drug that hasn’t even been shown to lower viral load.

Hydroxychloroquine in the other hand costs $1 per treatment, while chloroquine costs a measly 30 cents!  https://madisonarealymesupportgroup.com/2020/05/11/podcast-evidence-supporting-hcq-azithromycin-for-covid-19/

Early results of the first clinical trial of remdesivir against placebo in coronavirus showed modest benefits, according to The New York Times. Surviving patients given remdesivir were discharged four days sooner than patients given placebo, though no criteria were given for determining improvement. Death rates were not significantly different. About 25% of patients receiving remdesivir had potentially severe side effects, including multiple organ dysfunction, septic shock, acute kidney injury and low blood pressure. Another 23% showed evidence on lab tests of liver damage.

Gilead’s own press release revealed the side effect of acute respiratory failure in 6% of patients in the remdesivir five-day treatment group, and 10.7% of patients in the 10-day treatment group, clearly ominous findings with a drug designed to treat respiratory failure caused by COVID-19.

https://madisonarealymesupportgroup.com/2020/07/02/remdesivir-for-covid-19-not-backed-by-results/

Nutritional Supplements For COVID-19 Prophylaxis and Symptom De-Escalation

https://www.linkedin.com/pulse/nutritional-supplements-covid-19-prophylaxis-symptom-chris-newton/

NUTRITIONAL SUPPLEMENTS FOR COVID-19 PROPHYLAXIS AND SYMPTOM DE-ESCALATION

Chris Newton

Research Director CIMMBER (Center for Immuno-Metabolism, Microbiome and Bio-Energetic Research)

A week ago on Friday 3rd July 2020, a call was put out on LinkedIn to biomedical scientists and physicians and all informed individuals to form Consensus-COVID, an initiative to establish a consensus list of non-prescription agents for COVID prophylaxis and symptom de-escalation. The call has so far raised around 1900 views and responses from physicians, biomedical scientists and various other professionals. What follows is a distillation of these suggestions into two lists, one for COVID prophylaxis and the other for immediate use following the onset of symptoms.

Over the past three to four months, numerous articles have been written and posted at the this site and the site of other individuals in the list below, particularly Jeannette Hospers, and Dr Ian Brighthope, concerning what might be considered a ‘trinity mix’ for COVID-19, namely vitamin C, vitamin D and a zinc salt. These three compounds will form the immutable core of both consensus lists. For more information on this combination, I would thoroughly recommend visiting the site of Dr Ian Brighthope and listening to a recent interview.

The lists below are an amalgamation of suggestions made by the following individuals in response to the call:

  • Dr John H Abeles MD, General Partner at Northlea Partners, West Palm Beach, Florida Area
  • Dr Alex (Kennerly) Vasquez DO ND DC FACN. Physician, Researcher, Presenter, Academician, Editor, Consultant 
  • Dr Ian Brighthope, Founder and Managing Director at Entoura Pty Ltd, Greater Melbourne Area
  • David Steenblock, BS, MS, DO. President, CEO, Chief Scientist, Research Physician at Personalized Regenerative Medicine, San Clemente, California
  • Dr Alan Vinitsky. Physician, Owner at Enlightened Medicine. Owner Enlightened Nutritionals & Illumivites. Washington D.C. Metro Area
  • Dr William A. Shaver. Founder at Center of Meaning in Health and Disease, Lubbock, Texas Area
  • Dr. Larry G. Martin. Cellular research related to oxidative stress. Albany, Oregon  
  • Dr Emma Derbyshire. Research, Writing, Media Liasons, Epsom, Surrey, United Kingdom 
  • Dr Jeannette Hospers. Senior Scientist/Clinical Trial Manager, Basel Area, Switzerland
  • Dr Chris Newton. Director Center for Immuno-Metabolism, Microbiome and Bio-Energetic Research, Yorkshire, UK

It must be stated that the lists below do not constitute medical advice. The clinical science and indeed clinical philosophy behind this consensus is that agents will support immune cells and other somatic cell types by acting as immuno-modulators and not immuno-suppressants. In particular, it is hoped they will prevent the accumulation of oxidants and help tailor a more appropriate immune response to SARS-CoV-2. For an excellent review on optimal nutrition and antiviral immunity see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230749/

TABLE 1

1594895370673-2

The list above is relatively extensive and may be onerous for some individuals. A compromise might be made with supplement from companies such as Now Foods. They manufacture a combination of vitamins and minerals with addition of CoQ10 and other substances. The levels in these mixture are too low for vitamins C, and D and some minerals like magnesium, but for some of the B vitamins, they approach or exceed the lower limit in Table 1. By choosing single agent supplements, it will be possible to reach the upper limit of the range in Table 1.

In comparison to the list presented on July 3rd 2020, there are several additions and also one deletion- melatonin. This compound might be considered ‘optional’, to be taken before sleep in late evening at a dose level of 6-12mg. At least in the UK, melatonin is not easy to source and so one might consider natural products such as Feverfew. For an excellent review on natural sources of melatonin see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409706/ .

Whilst choline is easily available as a supplement, one might also consider natural sources, such as eggs (three eggs a day will reach the dose in Table 1). Also, Brazil nuts are high in selenium and 4-5 whole nuts will provide around 200 microg.

Although it has been suggested that butyrate is appropriate to add as a supplement, for now, it is considered ‘optional’. So, 500-1000mg per day might be appropriate. This substance is produced by bacterial fermentation in the gut and it is known to inhibit inflammatory responses (see post at this site and the work of Dr Larry Martin). The decision not to add butyrate to the list in Table 1 may change following further discussion with Dr Larry Martin and Dr William Shaver.

TABLE 2

1596824042032

Immediately at the onset of symptoms increase ascorbic acid (AA) intake and vitamin D as indicated in Table 2 above. Also increase zinc and quercetin along with NAC. The latter is a thiol antioxidant and a glutathione precursor.

Whilst dropping back to the protocol in Table 1 for vitamins C (0.5-2g four times daily) and D (4000IU/day- but have blood 25OHD measured if possible and maintain D at around 80-90nmolar), after symptoms have abated, all other components in Table 1 should be maintained, if possible, at the higher dose levels for 2 weeks after onset of symptoms. Following this period, the prophylaxis ‘protocol’ of Table 1 should be resumed.

None of the above is ‘set in stone’. They are merely suggestions and a continuing dialogue concerning merits of substances (and amounts) included, and others not included, would be much appreciated.

____________________

**Comment**

Great resource.  Here’s some more:  https://madisonarealymesupportgroup.com/2020/06/15/the-functional-medicine-approach-to-covid-19-virus-specific-nutraceutical-botanical-agents/ (Many other links at the end of this article for nutritional/supplemental treatments for COVID – and just beefing up the immune system)

Food As Medicine: A Possible Preventive Measure Against COVID-19

https://pubmed.ncbi.nlm.nih.gov/32468635/

. 2020 May 28;10.1002/ptr.6770.

doi: 10.1002/ptr.6770.Online ahead of print.

Food as Medicine: A Possible Preventive Measure Against Coronavirus Disease (COVID-19)

Abstract

The recent and ongoing outbreak of coronavirus disease (COVID-19) is a huge global challenge. The outbreak, which first occurred in Wuhan City, Hubei Province, China and then rapidly spread to other provinces and to more than 200 countries abroad, has been declared a global pandemic by the World Health Organization (WHO). Those with compromised immune systems and/or existing respiratory, metabolic or cardiac problems are more susceptible to the infection and are at higher risk of serious illness or even death.

The present review was designed to report important functional food plants with immunomodulatory and anti-viral properties. Data on medicinal food plants was retrieved and downloaded from English-language journals using online search engines. The functional food plants herein documented might not only enhance the immune system and cure respiratory tract infections but can also greatly impact the overall health of the general public. As many people in the world are now confined to their homes, inclusion of these easily accessible plants in the daily diet may help to strengthen the immune system and guard against infection by SARS-CoV-2. This might reduce the risk of COVID-19 and initiate a rapid recovery in cases of SARS-CoV-2 infection.

___________________

**Comment**

It is a rare day indeed when research actually mentions the importance of food in health.  Since we know it’s the immunocompromised who are hit hardest, that should be the focus – NOT MASKS, which in and of themselves are actually immunosuppressive and prohibit you from properly breathing, attract germs, and cause a lot of irritation.

For more:  https://madisonarealymesupportgroup.com/2020/06/15/the-functional-medicine-approach-to-covid-19-virus-specific-nutraceutical-botanical-agents/

For Dr. Waters’ presentation to the support group which goes far deeper into the topic:

It’s also quite telling that “authorities”, with a complicit media, won’t talk about effective treatments that ARE currently working – only expensive drugs that don’t work as well, and of course the supposed “magic bullet” vaccine the world is holding its breath for that’s scary as hell:  https://madisonarealymesupportgroup.com/2020/06/02/successful-covid-19-critical-care-stonewalled-by-cdc/

Oh, then there’s that sticky little issue that the NIH is in bed with Moderna, a manufacturer of the COVID vaccine, and our “authorities” stand to gain large profit from it:  https://madisonarealymesupportgroup.com/2020/07/08/new-docs-nih-owns-half-of-moderna-vaccine/

 

MTHFR & Lyme

https://www.treatlyme.net/guide/mthfr-and-detoxification-a-lyme-byte

MTHFR detoxification in Lyme disease by Marty Ross MD image

updated 6/26/20

Marty Ross MD on MTHFR & Lyme

In this video article, Marty Ross MD discusses MTHFR detoxification genetic defect in Lyme disease. Watch the video to learn:

  • what the MTHFR genetic defect is,
  • how MTHFR defect can interfere with detoxification,
  • why it is not always necessary to correct for this defect,
  • how the gut microbiome can fix this problem even if you have a genetic defect,
  • when to take supplements to correct this problem.
(See link for article and video)
__________________________

https://madisonarealymesupportgroup.com/2019/04/13/folate-you-perfect-together/

https://madisonarealymesupportgroup.com/2018/08/01/methylation-what-you-need-to-know/

https://madisonarealymesupportgroup.com/2018/03/23/altered-dna-methylation-mental-illness-lyme-msids/

https://madisonarealymesupportgroup.com/2018/04/09/3-part-series-on-genetic-mutations/

https://suzycohen.com/articles/methylation-problems/  Pharmacist Suzy Cohen states 100’s of diseases are the result of methylation problems, including Lyme, chronic viral infections, schizophrenia, Dementia/Alzheimer’s, addictive behavior, insomnia, cancer, and more. (Wonderful 1 minute video explaining methylation in link)

While methylation problems do not directly cause Lyme (it is caused by a pleomorphic bacteria called borrelia) it causes severe symptoms due to the inability to clear infections & their by-products, as well as repairing the damage they cause.

If you are extremely sensitive to medicine you probably have a methylation problem.